University of Rochester
EMERGENCY INFORMATIONCALENDARDIRECTORYA TO Z INDEXCONTACTGIVINGTEXT ONLY

Office of Research and Project Administration

Please see below for clarification regarding registration of clinical trials in ClinicalTrials.gov. NOT-OD-09-030 may also be accessed at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-030.html 

Please contact your ORPA Research Administrator with any questions.

Donna Beyea - x5-8037

Gayle Elledge - x 5-1502

Brenda Kavanaugh - x5-1504

Tammie Martin - x3-3960

Jane Tolbert - x5-4210

Cheryl Williams - x5-1503

 

Clarification of NOT-OD-08-014 and NOT-OD-08-023 Regarding Registration in ClinicalTrials.gov

Notice Number: NOT-OD-09-030

Key Dates
Release Date: December 11, 2008

Issued by
National Institutes of Health (NIH), (http://www.nih.gov)

On November 16, 2007, and December 21, 2007, the National Institutes of Health issued the following notices (respectively):

The purpose of this Notice is to clarify the criteria under “When Must I Register My Trial?”. The criteria should read as follows:

When Must I Register My Trial?

1) Trials initiated after 9/27/2007 must be registered in full not later than 21 days after the first patient is enrolled, or by 12/26/2007, whichever is later.

2) Trials that were initiated on or before 9/27/2007 and “ongoing” as of 12/26/2007 and do involve a “serious or life threatening disease or condition” must be registered in full by 12/26/2007.

3) Trials that were “ongoing” as of 9/27/2007 and do not involve a “serious or life threatening disease or condition” must be registered in full by 9/27/2008.

4) Trials that were “ongoing” as of 9/27/2007, do involve a “serious or life threatening disease or condition,” and are completed (meaning, not “ongoing”) by 12/26/2007 are not subject to these requirements, though they may be subject to pre-existing registration requirements. (“Ongoing” in this context means a trial had one or more patients enrolled, but had not examined the final subject or provided the final subject an intervention for the purposes of final collection of data for the primary outcome.)

All other aspects of the Notices remain unchanged.

Inquiries

Specific questions about this Notice should be directed to:

Office of Extramural Programs
Office of Extramural Research
National Institutes of Health
Email: OEPMailbox@mail.nih.gov

**************************************************************

Jane Tolbert
Research Administrator
Office of Research & Project Administration
University of Rochester
503 Hylan Building
RC Box 270140
Rochester, NY 14627
Phone: 585-275-4210
Fax: 585-275-9492
Email: jtolbert@orpa.rochester.edu